PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $993,000 | +7.2% | 337,800 | 0.0% | 0.14% | -7.4% |
| Q4 2017 | $926,000 | -12.9% | 337,800 | +7.7% | 0.15% | -16.8% |
| Q3 2017 | $1,063,000 | +2937.1% | 313,507 | +3035.1% | 0.18% | +1276.9% |
| Q4 2015 | $35,000 | -85.8% | 10,000 | -79.6% | 0.01% | -84.3% |
| Q3 2015 | $246,000 | -17.7% | 49,000 | +5.4% | 0.08% | -8.8% |
| Q2 2015 | $299,000 | -8.6% | 46,500 | 0.0% | 0.09% | +8.3% |
| Q1 2015 | $327,000 | +63.5% | 46,500 | +79.5% | 0.08% | +61.5% |
| Q4 2014 | $200,000 | +108.3% | 25,900 | +100.8% | 0.05% | +67.7% |
| Q3 2014 | $96,000 | – | 12,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |